Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 727,566 | 793,361 | 756,564 | 750,342 | 611,657 |
| Marketable Securities | 739 | 703 | 763 | N/A | N/A |
| Receivables | 373,091 | 331,096 | 297,614 | 314,114 | 339,304 |
| Inventories | 31,264 | 30,424 | 32,415 | 34,594 | 31,833 |
| Other current assets | 198,266 | 180,804 | 204,381 | 230,352 | 220,892 |
| TOTAL | $1,408,062 | $1,388,261 | $1,338,119 | $1,389,280 | $1,285,799 |
| Non-Current Assets | |||||
| PPE Net | 466,720 | 470,608 | 478,481 | 472,663 | 476,113 |
| Investments And Advances | 85,022 | 80,205 | 78,017 | 73,757 | 86,304 |
| Intangibles | 894,320 | 926,957 | 936,973 | 937,083 | 941,661 |
| Other Non-Current Assets | 337,999 | 361,729 | 364,411 | 356,253 | 368,725 |
| TOTAL | $1,784,061 | $1,839,499 | $1,857,882 | $1,839,756 | $1,872,803 |
| Total Assets | $3,192,123 | $3,227,760 | $3,196,001 | $3,229,036 | $3,158,602 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,668 | 17,840 | 17,234 | 17,288 | 11,550 |
| Accrued Expenses | 376,212 | 369,256 | 317,422 | 376,498 | 360,915 |
| Other current liabilities | 37,094 | 31,382 | 36,031 | 39,615 | 37,111 |
| TOTAL | $443,507 | $437,790 | $388,785 | $457,485 | $441,877 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 145,391 | 157,702 | 192,494 | 188,099 | 199,449 |
| TOTAL | $145,745 | $158,024 | $192,965 | $188,532 | $199,697 |
| Total Liabilities | $589,252 | $595,814 | $581,750 | $646,017 | $641,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,540 | 95,506 | 95,844 | 96,066 | 96,377 |
| Common Shares | 94 | 94 | 94 | 95 | 95 |
| Retained earnings | 2,604,358 | 2,634,980 | 2,618,163 | 2,601,552 | 2,543,413 |
| Other shareholders' equity | -1,581 | -3,128 | -4,006 | -18,628 | -26,480 |
| TOTAL | $2,602,871 | $2,631,946 | $2,614,251 | $2,583,019 | $2,517,028 |
| Total Liabilities And Equity | $3,192,123 | $3,227,760 | $3,196,001 | $3,229,036 | $3,158,602 |